首页 | 本学科首页   官方微博 | 高级检索  
检索        

99Tcm-MIBI SPECT/CT联合D-二聚体鉴别诊断口腔颌面部病变良恶性
引用本文:郭林,刘玉婷,金刚,尹学权,王瑶,李晨龙.99Tcm-MIBI SPECT/CT联合D-二聚体鉴别诊断口腔颌面部病变良恶性[J].中国医学影像技术,2014,30(10):1477-1480.
作者姓名:郭林  刘玉婷  金刚  尹学权  王瑶  李晨龙
作者单位:哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086;哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086;哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086;哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086;哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086;哈尔滨医科大学附属第二医院核医学科, 黑龙江 哈尔滨 150086
基金项目:黑龙江省卫生厅科研项目(2004-118)。
摘    要:目的 探讨99Tcm-MIBI SPECT/CT显像联合血浆D-二聚体检测鉴别诊断口腔颌面部病变良恶性的价值。方法 对57例经病理确诊的口腔颌面部肿块患者行99Tcm-MIBI SPECT/CT显像并测量血浆D-二聚体,以术后病理结果为金标准,计算并比较99Tcm-MIBI SPECT/CT显像与血浆D-二聚体两种方法单独及联合诊断口腔额面部恶性肿瘤的灵敏度(敏感度)、特异度及准确率。结果 99Tcm-MIBI SPECT/CT显像和血浆D-二聚体检测单独及联合诊断口腔颌面部恶性肿瘤的灵敏度(敏感度)、特异度、准确率分别为72.73%(16/22)、82.86%(29/35)、78.95%(45/57),68.18%(15/22)、74.29%(26/35)、71.93%(41/57)及95.45%(21/22)、94.29%(33/35)、94.74%(54/57),联合诊断恶性肿瘤的敏感度和准确率高于99Tcm-MIBI SPECT/CT(P均<0.05),联合诊断敏感度、特异度和准确率均高于D-二聚体检测(P均<0.05)。结论 99Tcm-MIBI SPECT/CT显像与血浆D-二聚体检测联合应用可提高二者单独应用鉴别口腔颌面部病变良恶性的效能,具有重要临床价值。

关 键 词:口颌疾病  肿瘤  体层摄影术    发射型计算机    单光子  D-二聚体
收稿时间:2014/4/22 0:00:00
修稿时间:2014/6/19 0:00:00

99Tcm-MIBI SPECT/CT combined with D-dimer measurement in differentially diagnosing benign and malignant lesions of oral and maxillofacial
GUO Lin,LIU Yu-ting,JIN Gang,YIN Xue-quan,WANG Yao and LI Chen-long.99Tcm-MIBI SPECT/CT combined with D-dimer measurement in differentially diagnosing benign and malignant lesions of oral and maxillofacial[J].Chinese Journal of Medical Imaging Technology,2014,30(10):1477-1480.
Authors:GUO Lin  LIU Yu-ting  JIN Gang  YIN Xue-quan  WANG Yao and LI Chen-long
Institution:Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;Department of Nuclear Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
Abstract:Objective To evaluate the value of 99Tcm-MIBI SPECT/CT imaging combined with plasma D-dimer (D-D) measurement in differentially diagnosing benign and malignant lesions of oral and maxillofacial. Methods Fifty-seven patients of maxillofacial masses confirmed by pathology underwent 99Tcm-MIBI SPECT/CT imaging and plasma D-D measurement. The sensitivity, specificity and accuracy of 99Tcm-MIBI SPECT/CT imaging, plasma D-D measurement and combination of the two methods in diagnosing malignant tumors of oral and maxillofacial were calculated with pathological results as gold standard. Results The sensitivity, specificity and accuracy in diagnosing malignant tumors of oral and maxillofacial was 72.73% (16/22), 82.86% (29/35), 78.95% (45/57) for 99Tcm-MIBI SPECT/CT, 68.18% (15/22), 74.29% (26/35), 71.93% (41/57) for plasma D-D measurement and 95.45% (21/22), 94.29% (33/35), 94.74% (54/57) for combination of the two methods. The sensitivity and accuracy of combination dignosis were higher than those of 99Tcm-MIBI SPECT/CT, and the sensitivity, specificity and accuracy of combination dignosis were higher than those of plasma D-D measurement (all P<0.05). Conclusion 99Tcm-MIBI SPECT/CT fusion imaging combined with plasma D-D measurement improves the ability of the single methods in differentially diagnosing benign and malignant lesions of oral and maxillofacial, with significant clinical value.
Keywords:Stomatognathic diseases  Neoplasms  Tomography  emission-computed  single-photon  D-dimer
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号